نتایج جستجو برای: von willebrand factor

تعداد نتایج: 931957  

Journal: :Blood 1981
Z M Ruggeri T S Zimmerman

We have analyzed the multimeric structure of factor VIII/von Willebrand factor in plasma by sodium dodecyl sulfate electrophoresis using gels of varying porosity and a discontinuous buffer system. Factor VIII/von Willebrand factor bands were identified by reaction with 125I-labeled affinity-purified antibody and subsequent autoradiography. In 1% agarose gels, normal plasma displayed a series of...

Journal: :Annals of the rheumatic diseases 1991
G Brevetti M De Caterina V D Martone S Corrado A Silvestro G Spadaro F Scopacasa

Adhesion molecules play a role in the inflammation and pathogenesis of vascular diseases. In 13 patients with primary Raynaud's phenomenon, 19 with Raynaud's phenomenon associated with connective tissue disease, and 16 control subjects, we measured plasma levels of soluble forms of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and von Willebrand factor. Patie...

Journal: :Stroke 2011
Hugh S Markus Charles McCollum Chris Imray Michael A Goulder Jim Gilbert Alice King

BACKGROUND AND PURPOSE Inhibition of von Willebrand factor offers a novel approach to prevention of stroke and myocardial ischemia but has not yet been demonstrated to show efficacy on clinically relevant end points. ARC1779 is an aptamer that inhibits the prothrombotic function of von Willebrand factor by binding to the A1 domain of von Willebrand factor and thereby blocking its interaction wi...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2014
A Cipolla D Cultrera C Teruzzi M Mantuano

Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, caused by a deficiency or abnormality of the Von Willebrand Factor (VWF). The mainstays of treatment are therapy with Desmopressin (DDAVP) and replacement therapy with Factor VIII-containing VWF product (FVIII/VWF). Therapy with FVIII/VWF can be administered as Long-term prophylaxis (LTP) in the more severe forms of th...

Journal: :Stroke 2010
Renske G Wieberdink Marianne C van Schie Peter J Koudstaal Albert Hofman Jacqueline C M Witteman Moniek P M de Maat Frank W G Leebeek Monique M B Breteler

BACKGROUND AND PURPOSE Many studies have investigated the role of plasma von Willebrand factor level in coronary heart disease, but few have investigated its role in stroke. The aim of this study was to determine if von Willebrand factor levels are associated with the risk of stroke. METHODS The study was part of the Rotterdam Study, a large population-based cohort study among subjects aged ≥...

Journal: :Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2008
Anwar M Al-Awadhi Suad M AlFadhli Nada Y Mustafa Prem N Sharma

OBJECTIVES This study aimed at determining the effects of cigarette smoking based on gender, on several hematological parameters and von Willebrand factor protein in the asymptomatic Arab population of Kuwait. SUBJECTS AND METHODS Ninety-two subjects participated in this study: 55 males (31 smokers and 24 nonsmokers) and 37 females (18 smokers and 19 nonsmokers). Complete blood count results ...

Journal: :The Journal of Cell Biology 1991
N Kieffer L A Fitzgerald D Wolf D A Cheresh D R Phillips

Glycoprotein IIb-IIIa (alpha IIb beta 3) and the vitronectin receptor (alpha v beta 3), two integrins that share the common beta 3 subunit, have been reported to function as promiscuous receptors for the RGD-containing adhesive proteins fibrinogen, vitronectin, fibronectin, von Willebrand factor, and thrombospondin. The present study was designed to establish a cell system for the expression of...

Journal: :Blood 2006
Sandra L Haberichter Michael Balistreri Pamela Christopherson Patricia Morateck Stefana Gavazova Daniel B Bellissimo Marilyn J Manco-Johnson Joan Cox Gill Robert R Montgomery

Type 1 von Willebrand disease (VWD) is characterized by a partial quantitative deficiency of von Willebrand factor (VWF). Few VWF gene mutations have been identified that cause dominant type 1 VWD. The decreased survival of VWF in plasma has recently been identified as a novel mechanism for type 1 VWD. We report 4 families with moderately severe type 1 VWD characterized by low plasma VWF:Ag and...

Journal: :Acta haematologica 2012
Augusto B Federici Paula James

Von Willebrand disease type 3 (VWD3) is the most severe form of this bleeding disorder due to the almost complete deficiency of von Willebrand factor (VWF). VWD3 is inherited as an autosomal recessive trait. While heterozygous carriers exhibit mild or no bleeding symptoms, most patients with VWD3, which is characterized by undetectable levels of VWF antigen (VWF:Ag) and reduced concentrations (...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید